KLK3 and prostate carcinoma: Other studies have reported mixed outcomes whereby, men with prostate-specific antigen levels below 4.0 ng/mL had prostate cancer and on the other hand, men with higher levels of prostate-specific antigen did not have prostate cancer [18].